TRDA Projected Dividend Yield
Entrada Therapeutics Inc ( NASDAQ : TRDA )Entrada Therapeutics is a biotechnology company. Co. is focused on the development of Endosomal Escape Vehicle (EEV) therapeutics for rare neuromuscular diseases, including Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1. In its neuromuscular disease programs, Co. links EEVs to small strands of nucleic acids called oligonucleotides, including phosphorodiamidate morpholino oligomers (PMOs). Co. is developing EEV-PMOs that promote the skipping of these mutations associated with DMD. Co.'s therapeutic candidate, ENTR-601-44, is being developed for patients with DMD that are exon 44 skipping amenable. 20 YEAR PERFORMANCE RESULTS |
TRDA Dividend History Detail TRDA Dividend News TRDA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |